- Home
- IBIO vs NAII Comparison
IBIO vs NAII Comparison
Compare IBIO & NAII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IBIO
- NAII
- Stock Information
- Founded
- IBIO 2008
- NAII 1980
- Country
- IBIO United States
- NAII United States
- Employees
- IBIO N/A
- NAII N/A
- Industry
- IBIO Biotechnology: Pharmaceutical Preparations
- NAII Medicinal Chemicals and Botanical Products
- Sector
- IBIO Health Care
- NAII Health Care
- Exchange
- IBIO Nasdaq
- NAII Nasdaq
- Market Cap
- IBIO 24.3M
- NAII 26.2M
- IPO Year
- IBIO N/A
- NAII 1987
- Fundamental
- Price
- IBIO $2.83
- NAII $4.21
- Analyst Decision
- IBIO Strong Buy
- NAII
- Analyst Count
- IBIO 3
- NAII 0
- Target Price
- IBIO $4.87
- NAII N/A
- AVG Volume (30 Days)
- IBIO 132.6K
- NAII 6.5K
- Earning Date
- IBIO 02-07-2025
- NAII 02-11-2025
- Dividend Yield
- IBIO N/A
- NAII N/A
- EPS Growth
- IBIO N/A
- NAII N/A
- EPS
- IBIO N/A
- NAII N/A
- Revenue
- IBIO $175,000.00
- NAII $112,977,000.00
- Revenue This Year
- IBIO N/A
- NAII N/A
- Revenue Next Year
- IBIO N/A
- NAII N/A
- P/E Ratio
- IBIO N/A
- NAII N/A
- Revenue Growth
- IBIO 250.00
- NAII N/A
- 52 Week Low
- IBIO $1.02
- NAII $4.02
- 52 Week High
- IBIO $4.98
- NAII $7.26
- Technical
- Relative Strength Index (RSI)
- IBIO 61.21
- NAII 45.33
- Support Level
- IBIO $2.40
- NAII $4.15
- Resistance Level
- IBIO $2.93
- NAII $4.25
- Average True Range (ATR)
- IBIO 0.19
- NAII 0.07
- MACD
- IBIO 0.04
- NAII 0.00
- Stochastic Oscillator
- IBIO 83.87
- NAII 24.00
About IBIO iBio Inc.
iBio Inc is a preclinical stage biotechnology company that leverages the power of Artificial Intelligence (AI) for the development of precision antibodies. CDMO. Its technology stack is designed to minimize downstream development risks by employing AI-guided epitope-steering and monoclonal antibody (mAb) optimization.
About NAII Natural Alternatives International Inc.
Natural Alternatives International Inc is engaged in formulating, manufacturing, and marketing nutritional supplements. It offers vitamins, minerals, herbs, and other supplements, as well as other healthcare products to customers within the United States and internationally. Its business activity is operated through Private-Label Contract Manufacturing and Patent & Trademark Licensing segment. The company derives the majority of revenue from Private-Label Contract Manufacturing which is engaged in providing manufacturing services to companies that market and distribute nutritional supplements and other healthcare products, whereas the Patent and Trademark Licensing segment includes royalty income from its license and supply agreements associated with the sale.